Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Cellectis S.A. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 34 | +7 |
| Shares | 8.31M | 10.1K | 10.5M | +2.25M (+27.1%) |
| Value | $23.7M | $28.9K | $51.1M | +$27.4M (+115.8%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Cellectis S.A. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Asset Management Americas Inc | 3,178,620 | $15.4M | 0.00% |
| BlackRock, Inc. | 384,299 | $1.86M | 0.00% |
| Nomura Asset Management International Inc. | 226,875 | $1.10M | 0.00% |
| Point72 Asset Management, L.P. | 27,314 | $132.2K | 0.00% |
| Global Retirement Partners, LLC | 7,038 | $34.1K | 0.00% |
| Quadrant Capital Group LLC | 2,761 | $13.4K | 0.00% |
| Parallel Advisors, LLC | 1,479 | $7.16K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,133 | $5.48K | 0.00% |
| GAMMA Investing LLC | 1,107 | $5.36K | 0.00% |
| Signaturefd, LLC | 662 | $3.20K | 0.00% |
| SageView Advisory Group, LLC | 115 | $557 | 0.00% |
| Group One Trading, L.P. | 97 | $469 | 0.00% |
| CWM Advisors, LLC | 8 | $37 | 0.00% |
Sold out (6)
Institutions that held Cellectis S.A. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Macquarie Group Ltd | 226,875 | $647.0K |
| Millennium Management LLC | 57,740 | $164.6K |
| Virtu Financial LLC | 25,211 | $72.0K |
| Baird Financial Group, Inc. | 11,090 | $31.6K |
| JPMorgan Chase & Co | 4,945 | $14.1K |
| Principal Securities, Inc. | 179 | $510 |
Not filed for Q4 2025 yet (1)
Institutions that held Cellectis S.A. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| First Affirmative Financial Network | 10,149 | $28.9K |